Skip to main content
. 2005 Sep;91(9):1167–1172. doi: 10.1136/hrt.2004.038620

Figure 1.

Figure 1

 Kaplan-Meier survival analysis (cumulative proportion surviving) of 57 patients with diagnosed arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C) (time from correct diagnosis to cardiac death or heart transplantation). The numbers of patients remaining at risk for death or heart transplantation during follow up (FU) are listed beneath the plot.